BioSpace News Archive

Exothera SA announced a collaboration with LogicBio® Therapeutics and Polyplus-transfection® SA. for the development of a highly scalable AAV manufacturing platform with a capacity from 200 L to 2,000 L.

DJO® is now part of the Enovis™ family.* Enovis Corporation, an innovation-driven medical technology growth company, announced the launch of the Arsenal Ankle Plating System™.

Immunic, Inc. announced that data from its phase 2 EMPhASIS trial of lead asset, vidofludimus calcium, in patients with relapsing-remitting multiple sclerosis, has been published in the peer reviewed journal, Annals of Clinical and Translational Neurology.

Kamada Ltd. (NASDAQ & TASE: KMDA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, announced today the promotions of Shavit Beladev to Vice President responsible for the Company’s Plasma Operations, and Boris Gorelik to Vice President of Business Development and Strategic Programs, both reporting to Kamada’s CEO, Amir London.

Wilmington, Delaware, United States: Owing to a high incidence of chronic diseases, the home infusion therapy market is witnessing uptick in demand.

Wilmington, Delaware, United States: Transparency Market Research has published a new report titled, ‘Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Wilmington, Delaware, United States: According to the report, the global regulatory affairs outsourcing market was valued at US$ 4.5 Bn in 2020 and is projected to expand at a CAGR of 19.0% from 2021 to 2028.

Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including Parkinson Disease and various cancers, today announced that the Company presentation at BIO International Convention is now available at https://www.oncotelic.com/wp-content/uploads/2022/06/BIO-2022-digital-slides.pdf .

PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a key opinion leader (“KOL”) webinar on the cost of managing surgical site infections (“SSIs”) on Thursday, June 23, 2022, at 10:00 AM Eastern Time.

Paige, a global leader in clinical AI applications in pathology, today announced a collaboration with Janssen Research & Development, LLC (Janssen) to evaluate the potential of a hematoxylin and eosin (H&E)-based, artificial intelligence (AI)-powered biomarker test to predict the presence of certain actionable alterations in the fibroblast growth factor receptor (FGFR) genes in patients with advanced urothelial cancer, also known as bladder cancer.